We are live on
!
Find out more
ZCM
Zebra Capital Management Portfolio holdings
AUM
$20M
1-Year Est. Return
2.24%
This Fund
S&P 500
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+2.24%
3 Year Est. Return
+142.1%
5 Year Est. Return
+107.07%
10 Year Est. Return
+252.16%
AUM
$85.3M
AUM Growth
-$5.52M
(-6.1%)
Cap. Flow
-$9.15M
Cap. Flow
% of AUM
-10.73%
Top 10 Holdings %
Top 10 Hldgs %
18.82%
Holding
174
New
5
Increased
19
Reduced
125
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DMC Global
BOOM
|
+$277K |
| 2 |
International Seaways
INSW
|
+$201K |
| 3 |
Astrana Health
ASTH
|
+$197K |
| 4 |
CUTR
Cutera, Inc.
CUTR
|
+$180K |
| 5 |
QADA
QAD Inc.
QADA
|
+$176K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYKE
SYKES Enterprises Inc
SYKE
|
+$1.03M |
| 2 |
DSSI
Diamond S Shipping Inc. Common Shares
DSSI
|
+$753K |
| 3 |
PFBI
Premier Financial Bancorp
PFBI
|
+$233K |
| 4 |
Aaon
AAON
|
+$223K |
| 5 |
AMNB
American National Bankshares Inc
AMNB
|
+$220K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.47% |
| 2 | Industrials | 15.73% |
| 3 | Financials | 14.15% |
| 4 | Technology | 13.65% |
| 5 | Consumer Discretionary | 12.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Anika Therapeutics
ANIK
$215M
| $236K | 0.28% |
5,455
-589
| -10% | -$25.1K |
|
|
NAGE
127
Niagen Bioscience
NAGE
$256M
| $227K | 0.27% |
23,020
+737
| +3% | +$6.43K |
|
|
FSFG
128
DELISTED
First Savings Financial Group
FSFG
| $225K | 0.26% |
9,228
-996
| -10% | -$23.6K |
|
|
BFS
129
Saul Centers
BFS
$858M
| $223K | 0.26% |
4,916
-531
| -10% | -$23K |
|
130
Security National Financial
SNFCA
$248M
| $223K | 0.26% |
34,087
-3,681
| -10% | -$23.5K |
|
|
EPAY
131
DELISTED
Bottomline Technologies Inc
EPAY
| $222K | 0.26% |
5,974
+161
| +3% | +$6.63K |
|
132
MetroCity Bankshares
MCBS
$1.02B
| $220K | 0.26% |
12,533
-1,012
| -7% | -$16.8K |
|
133
Voyager Therapeutics
VYGR
$181M
| $220K | 0.26% |
53,360
-5,764
| -10% | -$26.1K |
|
134
Capital Bancorp
CBNK
$616M
| $212K | 0.25% |
10,366
-1,120
| -10% | -$23.9K |
|
135
Forrester Research
FORR
$199M
| $210K | 0.25% |
4,584
-451
| -9% | -$19.5K |
|
|
QADA
136
DELISTED
QAD Inc.
QADA
| $210K | 0.25% |
+2,416
| New | +$176K |
|
|
ATRI
137
DELISTED
Atrion Corp
ATRI
| $207K | 0.24% |
334
-36
| -10% | -$22.5K |
|
138
Foster
FSTR
$421M
| $199K | 0.23% |
10,682
-1,154
| -10% | -$20.3K |
|
|
TRUE
139
DELISTED
TrueCar
TRUE
| $190K | 0.22% |
33,502
-2,918
| -8% | -$14.7K |
|
|
FSP
140
Franklin Street Properties
FSP
$49.8M
| $187K | 0.22% |
35,623
-3,847
| -10% | -$20.6K |
|
141
Information Services Group
III
$204M
| $183K | 0.21% |
31,247
-3,374
| -10% | -$17.5K |
|
|
SRGA
142
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $178K | 0.21% |
4,265
-400
| -9% | -$20.5K |
|
143
Travere Therapeutics
TVTX
$5.17B
| $154K | 0.18% |
10,545
-1,139
| -10% | -$22.5K |
|
|
MCBC
144
DELISTED
Macatawa Bank Corp
MCBC
| $148K | 0.17% |
16,870
-1,345
| -7% | -$12.8K |
|
145
Harrow
HROW
$1.44B
| $147K | 0.17% |
15,786
+505
| +3% | +$4.31K |
|
146
Viemed Healthcare
VMD
$447M
| $143K | 0.17% |
20,048
-2,166
| -10% | -$18.8K |
|
|
ATRS
147
DELISTED
Antares Pharma, Inc.
ATRS
| $124K | 0.15% |
28,438
| – | – |
|
|
ADMS
148
DELISTED
Adamas Pharmaceuticals
ADMS
| $124K | 0.15% |
23,400
| – | – |
|
149
Stereotaxis
STXS
$133M
| $118K | 0.14% |
12,190
| – | – |
|
150
Precigen
PGEN
$1.94B
| $114K | 0.13% |
17,448
-1,884
| -10% | -$13.2K |
|
Similar funds
CM
NPAM
6C
SCU
FFG
KE
GFT
CCM
Zebra Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Zebra Capital Management held 174 positions worth $85.3M, down 6.1% from $90.8M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Zebra Capital Management withdrew a net $9.15M in Q2 2021, closing 14 positions and reducing 125 holdings. Its most notable exit was SYKES Enterprises Inc, an estimated $1.03M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Zebra Capital Management opened a new position in DMC Global worth $283K.
- Zebra Capital Management's largest Q2 2021 buy was DMC Global: 5,040 shares worth $283K.
- Zebra Capital Management added most to International Seaways in Q2 2021, an estimated $201K increase.
- Zebra Capital Management's biggest Q2 2021 reduction was Kelly Services Class A, cutting an estimated $206K.
- Zebra Capital Management fully exited SYKES Enterprises Inc in Q2 2021, selling an estimated $1.03M.
- Zebra Capital Management's ten largest holdings make up 19% of its $85.3M portfolio in Q2 2021.
- Zebra Capital Management opened 5 new positions and closed 14 in Q2 2021.
- Zebra Capital Management's portfolio value fell 6.1% quarter-over-quarter to $85.3M.
Based on Zebra Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.